Cellectis SA (CLLS)
3.01
-0.05
(-1.63%)
USD |
NASDAQ |
May 16, 16:00
3.01
0.00 (0.00%)
After-Hours: 20:00
Cellectis Free Cash Flow: -25.82M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -25.82M |
| September 30, 2023 | -66.74M |
| June 30, 2023 | -76.02M |
| March 31, 2023 | -81.19M |
| December 31, 2022 | -89.88M |
| September 30, 2022 | -108.91M |
| June 30, 2022 | -118.12M |
| March 31, 2022 | -111.21M |
| December 31, 2021 | -123.12M |
| September 30, 2021 | -152.66M |
| June 30, 2021 | -148.70M |
| March 31, 2021 | -167.33M |
| December 31, 2020 | -124.68M |
| September 30, 2020 | -80.17M |
| June 30, 2020 | -76.34M |
| March 31, 2020 | -64.38M |
| December 31, 2019 | -82.10M |
| Date | Value |
|---|---|
| September 30, 2019 | -99.64M |
| June 30, 2019 | -87.77M |
| March 31, 2019 | -76.62M |
| December 31, 2018 | -73.02M |
| September 30, 2018 | -59.99M |
| June 30, 2018 | -60.00M |
| March 31, 2018 | -58.77M |
| December 31, 2017 | -54.98M |
| September 30, 2017 | -44.42M |
| June 30, 2017 | -32.54M |
| March 31, 2017 | -33.56M |
| December 31, 2016 | -46.74M |
| September 30, 2016 | -19.59M |
| June 30, 2016 | -20.68M |
| March 31, 2016 | -26.53M |
| December 31, 2015 | -0.822M |
Free Cash Flow Range, Past 5 Years
-167.33M
Minimum
Mar 2021
-25.82M
Maximum
Dec 2023
-99.20M
Average
-89.88M
Median
Dec 2022
Free Cash Flow Benchmarks
| DBV Technologies SA | -95.40M |
| Genfit SA | -- |
| Biophytis SA | -14.21M |
| Edap TMS SA | -20.54M |
| Adaptimmune Therapeutics PLC | -145.76M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 39.72M |
| Cash from Investing (Quarterly) | -13.65M |
| Cash from Financing (Quarterly) | 41.58M |
| Free Cash Flow Per Share (Quarterly) | 0.6035 |
| Free Cash Flow to Equity (Quarterly) | 37.77M |
| Free Cash Flow to Firm (Quarterly) | 61.34M |
| Free Cash Flow Yield | -15.02% |